TMO - Thermo Fisher Scientific Inc.
| Previous Close | 279.52 |
| Open | 278.00 |
| Bid | 270.03 x 1100 |
| Ask | 0.00 x 800 |
| Day's Range | 276.00 - 279.41 |
| 52 Week Range | 208.34 - 305.45 |
| Volume | 1,004,978 |
| Avg. Volume | 1,465,307 |
| Market Cap | 110.607B |
| Beta (3Y Monthly) | 1.15 |
| PE Ratio (TTM) | 31.54 |
| EPS (TTM) | 8.76 |
| Earnings Date | Oct 22, 2019 - Oct 28, 2019 |
| Forward Dividend & Yield | 0.76 (0.27%) |
| Ex-Dividend Date | 2019-09-16 |
| 1y Target Est | 307.12 |
- Thomson Reuters StreetEvents
Edited Transcript of TMO earnings conference call or presentation 24-Jul-19 12:30pm GMT
Q2 2019 Thermo Fisher Scientific Inc Earnings Call
- Simply Wall St.
A Look At The Intrinsic Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
How far off is Thermo Fisher Scientific Inc. (NYSE:TMO) from its intrinsic value? Using the most recent financial...
- InvestorPlace
4 Nanotech Stocks to Watch for Explosive Innovation
[Editor's note: "4 Nanotech Stocks to Watch for Explosive Innovation" was previously published in August 2018. It has since been updated to include the most relevant information available.]Within the broad and rapidly expanding technology sector, nanotechnology offers perhaps the most profound potential impact for society. On a purely scientific level, nanotech involves any innovation conducted at the nanoscale, which is between one to 100 nanometers. As this technology is perfected, it opens up the door to previously impossible mechanisms, making nanotech stocks a must-watch category.But what's behind this innovation? Physicist Richard Feynman, during a lecture in December 1959, introduced the concept that future technologies would enable scientists to "manipulate and control individual atoms and molecules." Over a decade later, professor Norio Taniguchi coined the term nanotechnology. However, it took substantial advancements in microscopic platforms before scientists could begin practical experimentations.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOnce they did, the positive implications from nanotech integration became readily apparent. According to Nano.gov, 25.4 million nanometers can "fit" inside an inch. A single sheet from a typical newspaper is approximately 100,000 nanometers thick.This tech and its astonishing scale will clearly set the pathway towards the next generation of super-computers. But this innovation reaches much further than that. With the ability to manipulate individual atoms, healthcare and the pharmaceutical industry can finally move beyond researching diseases, and towards their complete elimination. * 10 Cyclical Stocks to Buy (or Sell) Now Without question, nanotech stocks have the capacity to deliver enormous gains. Here are four examples to keep a close eye on. Nanotech Stocks to Watch: IBM (IBM)Source: Shutterstock I know exactly what you're thinking. With nanotech stocks representing the cutting edge in scientific innovations, why mention a legacy institution like IBM (NYSE:IBM)? It's a fair point. However, IBM is actually synonymous with this innovation. To not include IBM would be a crime against intellectual honesty.Primarily, "Big Blue" invented the scanning tunneling microscope in 1981 that allowed researchers unprecedented access to individual atoms and molecules. As Nano.gov confirms, the invention of this highly-specialized microscope catapulted the nanotech industry. Without it, scientists could only theorize about this concept.But what I appreciate about IBM as a viable opportunity among nanotech stocks is its fundamental stability. True, shares haven't performed the way investors would have liked in recent years. But this is a company that we can trust will be around in the next 50 to 100 years.Moreover, management is shifting away from its legacy businesses towards sectors that are relevant today. Whether we're talking nanotech, artificial intelligence or the blockchain, IBM has it covered. Plus, it currently offers a dividend yield of 4.6%. Nanotech Stocks to Watch: Taiwan Semiconductor (TSM)Source: Shutterstock Semiconductor companies have recently struggled with the harsh realities of Moore's Law. This is "a principle that states gains in CPU performance sharply declines once technology passes a critical maturation point."Obvious, semiconductors will continue to make strides. However, each dollar invested provides an increasingly smaller performance return. In prior generations, it was thought that a limit could be reached on how small a chip can get.The nanotech industry proved that we still have room to push the dimensional envelope further. As one of the top nanotech stocks within this sector, Taiwan Semiconductor (NYSE:TSM) is certainly a must-watch name.The challenge with most direct nanotech stocks is that they're incredibly speculative. TSM has a proven history of success. Of course, you pay for that privilege in its current share price, so upside potential is comparatively limited. Still, I like the idea of not getting completely wiped out. * 10 Cyclical Stocks to Buy (or Sell) Now Nanotech Stocks to Watch: Thermo Fisher Scientific (TMO)Source: Shutterstock When discussing nanotech stocks, a tendency exists to focus only on computers and electronics. Though they definitely can advantage the technology's performance and productivity output, they're not the only beneficiaries. With the ability to dive deeper into molecular structures, the biotech industry could likely generate the most meaningful impact.That's why investors should take a long look at Thermo Fisher Scientific (NYSE:TMO). As a medical diagnostics and research specialist, Thermo Fisher provides biotech and healthcare firms of all sizes with necessary equipment. As nanotech concepts increasingly transition from theory into reality, TMO is on the ground floor distributing these applied-science products.Better yet, TMO is an established, stable investment. On a year-to-date basis, TMO stock has gained 20%. Over the trailing five years, shares have returned over 100%. As with the other industry stalwarts, you pay for the privilege. But Thermo Fisher is unlikely to leave you hanging. Nanotech Stocks to Watch: Nanometrics (NANO)Source: Shutterstock Smaller, more powerful semiconductors and related electronic devices are only part of the nanotech story. At some point, we need companies that can drill down into the minutiae to perform assessment and quality-control operations. This is where Nanometrics (NASDAQ:NANO) comes into play.As a specialist in metrology, or the scientific study of measurements, Nanometrics develops the components used in semiconductor and solid-state device fabrication. Their platforms also dramatically improve manufacturing productivity while maintaining accuracy and precision.Sentiment has improved dramatically this year after some choppy performances in years past. NANO stock is up over 67% since January's opener.Those who are looking for a discounted opportunity may be somewhat disappointed with NANO's dramatic rise. However, the lift is fundamentally justified. Nanometrics features an exceptionally robust balance sheet, with highlights being zero debt and steadily rising cash. That gives management an extra cushion for future product investments. * 10 Cyclical Stocks to Buy (or Sell) Now Furthermore, NANO maintains strong profitability margins and above-average revenue growth. Recent outperformance in sales suggests more upside remaining for NANO stock.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Cyclical Stocks to Buy (or Sell) Now * 7 Biotech ETFs That Should Remain Healthy * 7 of the Hottest AI Stocks to Buy Now The post 4 Nanotech Stocks to Watch for Explosive Innovation appeared first on InvestorPlace.
- PR Newswire
Thermo Fisher Scientific Showcases New Innovations for the Clinic During AACC 2019
ANAHEIM, Calif. , Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest instruments, assays and software for ...
- GuruFocus.com
Acquisition Boosts Exact Sciences' Role in Cancer Diagnostics
Purchase of Genomic Health expands testing capabilities and R&D; Continue reading...
- GuruFocus.com
Thermo Fisher Scientific Inc (TMO) CEO Marc N Casper Sold $14.2 million of Shares
CEO of Thermo Fisher Scientific Inc (30-Year Financial, Insider Trades) Marc N Casper (insider trades) sold 50,000 shares of TMO on 07/30/2019 at an average price of $284.83 a share. Continue reading...
- Moody's
Alcami Corporation -- Moody's downgrades Alcami's CFR to Caa1, outlook stable
Moody's Investors Service ("Moody's") downgraded Alcami Corporation's ("Alcami") ratings, including the Corporate Family Rating (CFR) to Caa1 from B3 and the Probability of Default Rating to Caa1-PD from B3-PD. Moody's also downgraded the first lien senior secured bank credit facility rating to B3 from B2. The downgrade of the CFR to Caa1 reflects weakening in the company's operating performance, negative free cash flow and uncertainty around the timing of potential improvement.
- Motley Fool
3 Healthcare Stocks With Rising Expectations
It looks like 2019's going to be much better than expected for these giants operating in different corners of the healthcare sector.
- Motley Fool
10 Biggest Cancer-Fighting Stocks
The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.
- Zacks
What's in the Cards for AMETEK (AME) This Earnings Season?
AMETEK's (AME) Q2 earnings are likely to be driven by strong organic growth and contributions from acquisitions. Yet, ongoing trade tensions might affect its upcoming results.
- Zacks
What's in the Cards for Expedia Group's (EXPE) Q2 Earnings?
Strength across segments is likely to drive Expedia Group's (EXPE) second-quarter revenues.
Motley FoolThermo Fisher Scientific Inc (TMO) Q2 2019 Earnings Call Transcript
TMO earnings call for the period ending June 30, 2019.
- Investor's Business Daily
Two Medtech Giants Top Earnings Views And Narrowly Hold Onto Buy Points
Boston Scientific and Thermo Fisher Scientific stocks tripped Wednesday after the medtech companies beat second-quarter earnings forecasts, but reported roughly in-line revenue.
- Zacks
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, McDonald's, Canadian National and NextEra
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, McDonald's, Canadian National and NextEra
- Zacks
Thermo Fisher (TMO) Beats on Q2 Earnings, Lifts Guidance
Banking on a strong operational performance, Thermo Fisher (TMO) raises its 2019 revenue and earnings guidance.
- Reuters
UPDATE 2-Thermo Fisher misses organic revenue growth estimates, shares fall
Thermo Fisher Scientific Inc missed Wall Street estimates for quarterly organic revenue growth on Wednesday, hurt by an outage at one of its data centers, sending the company's shares down as much as 4.9%. The company, the world's largest maker of scientific instruments, disclosed in a regulatory filing last month that overheated equipment at one of its data centers had released a fire suppressant gas, temporarily affecting some systems. This had caused a delay in orders, lowering the company's organic revenue growth by 1% in the second quarter, Thermo Fisher said.
- Zacks
Thermo Fisher Scientific (TMO) Beats Q2 Earnings Estimates
Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.00% and -0.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- ACCESSWIRE
Thermo Fisher Scientific, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 24, 2019 / Thermo Fisher Scientific, Inc. (NYSE: TMO ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 24, 2019 at 8:30 ...
- PR Newswire
Thermo Fisher Scientific Reports Second Quarter 2019 Results
WALTHAM, Mass. , July 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, ...
- Investing.com
Thermo Fisher Scientific Earnings, Revenue Beat in Q2
Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported second quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
- TheStreet.com
[video]Thermo Fisher Scientific Expected to Earn $3 a Share
Thermo Fisher Scientific Inc. is expected to report earnings of $3 a share on sales of $6.3 billion before the market opens on Wednesday, based on a FactSet survey of 15 analysts. The stock has risen 10.8% since the company last reported earnings on April 24. Quarterly estimates have risen less than 1 cent a share in the past month.
- Zacks
Can Home Health Growth Support Amedisys' (AMED) Q2 Earnings?
Within Home Health, Amedisys (AMED) is expected to boost same-store volumes in Q2 via higher admissions and re-certifications.
- Zacks
Can New Product Menu Aid Zimmer Biomet's (ZBH) Q2 Earnings?
With consecutive product approvals, Zimmer Biomet (ZBH) becomes the first company on the global frontier with 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform.
- Zacks
Why Earnings Season Could Be Great for Thermo Fisher (TMO)
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
5 Corporate Giants Set to Win Big on Q2 Earnings This Week
Second-quarter 2019 earnings results so far are not as disappointing as expected initially. However, the forecast of overall earnings dip for two consecutive quarters is still looming large.
